DiscoverAxiom CatalystPre-emptive Medicine in Cardiometabolic Renal Disease
Pre-emptive Medicine in Cardiometabolic Renal Disease

Pre-emptive Medicine in Cardiometabolic Renal Disease

Update: 2025-07-11
Share

Description

In this episode of the Axiom Catalyst Life Sciences Podcast, Jai Bains speaks with Dr. Gayathri Swaminath, VP of Cardiovascular at Pioneering Medicines, about the evolving role of pre-emptive medicine in cardiometabolic renal disease, with a focus on chronic kidney disease. From redefining early intervention to exploring the role of biomarkers, and multi-omics, this conversation dives into the science, system barriers, and future outlook for tackling CKD earlier and more effectively.

Listen in to learn more!

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Pre-emptive Medicine in Cardiometabolic Renal Disease

Pre-emptive Medicine in Cardiometabolic Renal Disease

Axiom Healthcare Strategies